InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Eltoukhy Helmy, Chairman & CEO. Insider active across 1 companies, notably Guardant Health, Inc.. In total, 4 reports have been published. Total volume traded: €6.5m. The latest transaction was filed on 19 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€3m37,591 shares@ €86.11950.026% mcap97.4% of flow
COMMON STOCK
SEC:0001576280-21-000109·
Ideal exit: 16 Aug 2022 (T+270)
€3m37,591 shares@ €86.11950.026% mcap48.7% of flow
COMMON STOCK
SEC:0001576280-21-000109:0·
Ideal exit: 16 Aug 2022 (T+270)
€85,20423,923 shares@ €3.56160.0007% mcap2.6% of flow
COMMON STOCK
SEC:0001576280-21-000086·
€85,20423,923 shares@ €3.56160.0007% mcap1.3% of flow
COMMON STOCK
SEC:0001576280-21-000086:0·
4 of 4 declarations
About Eltoukhy Helmy
Helmy Eltoukhy is the Co-Chief Executive Officer of Guardant Health, Inc. He leads the company in developing diagnostic solutions for cancer. Helmy is committed to transforming healthcare through technological innovations and patient-centered approaches.
